ICH guideline
ICH S1B(R1) IWG: Training on Testing for Carcinogenicity of Pharmaceuticals
ICH guideline · Safety Guidelines
Key facts
| ICH code | S1B(R1) IWG |
|---|---|
| Title | Training on Testing for Carcinogenicity of Pharmaceuticals |
| Guideline series | Safety Guidelines |
| ICH summary (excerpt) | Further to the ICH Management Committee’s endorsement of the S1B(R1) IWG Concept Paper in March 2024, the S1B(R1) IWG was established to share experiences regarding ongoing implementation efforts for the new S1B(R1) weight of evidence (WoE) approach for carcinogenicity assessments, to develop potential best practices… |
| File | S1B(R1) Work Plan |
| File type | |
| File on ich.org | database.ich.org |
At a glance
- Yes Full text searchable in Orca1
- S1B(R1) Work Plan Files published by ICH
- None FDA guidance documents based on this guideline
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ICH guidelines
ICH guidelines harmonise the technical requirements for registering medicines in the ICH regions. Each guideline moves through a five-step process, from concept paper to adoption and implementation by regulators.